BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ozer H, Boztosun A, Açmaz G, Atilgan R, Akkar OB, Kosar MI. The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model. Reprod Sci 2013;20:26-32. [PMID: 22895024 DOI: 10.1177/1933719112452941] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Dolmans M, Donnez J. Emerging Drug Targets for Endometriosis. Biomolecules 2022;12:1654. [DOI: 10.3390/biom12111654] [Reference Citation Analysis]
2 Chung MS, Han SJ. Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis. Front Glob Womens Health 2022;3:856316. [DOI: 10.3389/fgwh.2022.856316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Canosa S, Carosso AR, Sestero M, Revelli A, Bussolati B. Endometrial Stem Cells and Endometriosis. Stem Cell Biology and Regenerative Medicine 2022. [DOI: 10.1007/978-3-030-90111-0_8] [Reference Citation Analysis]
4 Rogers MS. The Role of the Microenvironment in Endometriosis: Parallels and Distinctions to Cancer. Biomarkers of the Tumor Microenvironment 2022. [DOI: 10.1007/978-3-030-98950-7_28] [Reference Citation Analysis]
5 Bouquet de Joliniere J, Fruscalzo A, Khomsi F, Stochino Loi E, Cherbanyk F, Ayoubi JM, Feki A. Antiangiogenic Therapy as a New Strategy in the Treatment of Endometriosis? The First Case Report. Front Surg 2021;8:791686. [PMID: 34938768 DOI: 10.3389/fsurg.2021.791686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Brichant G, Laraki I, Henry L, Munaut C, Nisolle M. New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments. Int J Mol Sci 2021;22:10498. [PMID: 34638843 DOI: 10.3390/ijms221910498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
7 Abdelhamed A, Ezz El-Dawla R, Karadag AS, Agamia NF, Melnik BC. The impact of isotretinoin on the pituitary-ovarian axis: An interpretative review of the literature. Reprod Toxicol 2021;104:85-95. [PMID: 34224824 DOI: 10.1016/j.reprotox.2021.06.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cacciottola L, Donnez J, Dolmans MM. Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets? Int J Mol Sci 2021;22:7138. [PMID: 34281188 DOI: 10.3390/ijms22137138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
9 Thanatsis N, Filindris T, Siampalis A, Papageorgiou E, Panagodimou E, Adonakis G, Kaponis A. The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions. Obstet Gynecol Surv 2021;76:281-91. [PMID: 34032860 DOI: 10.1097/OGX.0000000000000888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chadchan SB, Cheng M, Parnell LA, Yin Y, Schriefer A, Mysorekar IU, Kommagani R. Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota. Hum Reprod 2019;34:1106-16. [PMID: 31037294 DOI: 10.1093/humrep/dez041] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 24.0] [Reference Citation Analysis]
11 Zani ACT, Valerio FP, Meola J, da Silva AR, Nogueira AA, Candido-Dos-Reis FJ, Poli-Neto OB, Rosa-E-Silva JC. Impact of Bevacizumab on Experimentally Induced Endometriotic Lesions: Angiogenesis, Invasion, Apoptosis, and Cell Proliferation. Reprod Sci 2020;27:1943-50. [PMID: 32542537 DOI: 10.1007/s43032-020-00213-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mir O, Ropert S, Morice P, Berveiller P. Clinical Activity of Sunitinib and Regorafenib in Endometriosis. Mayo Clin Proc 2019;94:2591-3. [PMID: 31806110 DOI: 10.1016/j.mayocp.2019.10.001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Acmaz G, Cınar L, Acmaz B, Aksoy H, Kafadar YT, Madendag Y, Ozdemir F, Sahin E, Muderris I. The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome. Biomed Res Int 2019;2019:2513067. [PMID: 31080813 DOI: 10.1155/2019/2513067] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
14 Barra F, Grandi G, Tantari M, Scala C, Facchinetti F, Ferrero S. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. Expert Opinion on Biological Therapy 2019;19:343-60. [DOI: 10.1080/14712598.2019.1581761] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 10.7] [Reference Citation Analysis]
15 Kulaksiz D, Kart C, Guven S, Akbulut K, Cobanoglu U, Deger O. Comparison of the effect of isotretionin and alitretionin on endometriotic implants and serum vascular endothelial growth factor level: an experimental study. Gynecol Endocrinol 2019;35:301-4. [PMID: 30600729 DOI: 10.1080/09513590.2018.1526275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Zheng W, Cao L, Xu Z, Ma Y, Liang X. Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms. Evid Based Complement Alternat Med 2018;2018:4128984. [PMID: 30402122 DOI: 10.1155/2018/4128984] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
17 Li Z, Liu H, Lang J, Zhang G, He Z. Effects of cisplatin on surgically induced endometriosis in a rat model. Oncol Lett 2018;16:5282-90. [PMID: 30250597 DOI: 10.3892/ol.2018.9275] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Ferrero S, Evangelisti G, Barra F. Current and emerging treatment options for endometriosis. Expert Opinion on Pharmacotherapy 2018;19:1109-25. [DOI: 10.1080/14656566.2018.1494154] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 16.5] [Reference Citation Analysis]
19 Barra F, Scala C, Mais V, Guerriero S, Ferrero S. Investigational drugs for the treatment of endometriosis, an update on recent developments.Expert Opin Investig Drugs. 2018;27:445-458. [PMID: 29708812 DOI: 10.1080/13543784.2018.1471135] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
20 Barra F, Ferrero S. The use of retinoic acid for the treatment of endometriosis. Arch Gynecol Obstet 2018;298:231-2. [DOI: 10.1007/s00404-018-4774-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Cousins FL, O DF, Gargett CE. Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol 2018;50:27-38. [PMID: 29503126 DOI: 10.1016/j.bpobgyn.2018.01.011] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 19.5] [Reference Citation Analysis]
22 Kebapcilar AG, Ilhan TT, Dursunoglu D, Kebapcilar L, Ipekci SH, Baldane S, Ucar MG, Kirac CO, Kurt K, Celik C. Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats. Gynecological Endocrinology 2017;33:923-7. [DOI: 10.1080/09513590.2017.1320384] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sazonova NG, Salmina AB, Makarenko TA. The neoangiogenesis in the development of endometriosis (a review). Probl reprod 2017;23:12. [DOI: 10.17116/repro201723312-18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Liu S, Xin X, Hua T, Shi R, Chi S, Jin Z, Wang H. Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0166658. [PMID: 27855197 DOI: 10.1371/journal.pone.0166658] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
25 Cinar SL, Kartal D, Aksoy H, Cinar E, Aydin T, Öz L, İmamoğlu H, Ferahbas A, Borlu M. Long-term effect of systemic isotretinoin on female fertility. Cutaneous and Ocular Toxicology 2017;36:132-4. [DOI: 10.3109/15569527.2016.1172234] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
26 Yildiz C, Kacan T, Akkar OB, Karakus S, Seker M, Kacan SB, Ozer H, Cetin A. Effect of imatinib on growth of experimental endometriosis in rats. European Journal of Obstetrics & Gynecology and Reproductive Biology 2016;197:159-63. [DOI: 10.1016/j.ejogrb.2015.12.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
27 Farkhat KN, Savilova AM, Makiyan ZN, Adamyan LV. The role of stem cells in the pathogenesis of endometriosis (а review). Probl reprod 2016;22:20. [DOI: 10.17116/repro201622120-27] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Leone Roberti Maggiore U, Ferrero S. An overview of early drug development for endometriosis. Expert Opinion on Investigational Drugs 2016;25:227-47. [DOI: 10.1517/13543784.2016.1126579] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Taskin MI, Gungor AC, Adali E, Yay A, Onder GO, Inceboz U. A Humanized Anti-Interleukin 6 Receptor Monoclonal Antibody, Tocilizumab, for the Treatment of Endometriosis in a Rat Model. Reprod Sci 2015;23:662-9. [DOI: 10.1177/1933719115612134] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
30 Dhesi AS, Morelli SS. Endometriosis: a role for stem cells. Womens Health (Lond) 2015;11:35-49. [PMID: 25581054 DOI: 10.2217/whe.14.57] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
31 Leconte M, Santulli P, Chouzenoux S, Marcellin L, Cerles O, Chapron C, Dousset B, Batteux F. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis. Reprod Sci 2015;22:1171-80. [PMID: 26169036 DOI: 10.1177/1933719115592708] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
32 Taylor RN, Kane MA, Sidell N. Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways. Semin Reprod Med 2015;33:246-56. [PMID: 26132929 DOI: 10.1055/s-0035-1554920] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
33 Che X, Chen Y, Chen C, Ye X, Zhu H. Non-hormonal targets underlying endometriosis: A focus on molecular mechanisms: N ON -H ORMONAL T ARGETSOF E NDOMETRIOSIS. Mol Reprod Dev 2015;82:410-31. [DOI: 10.1002/mrd.22493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Yildiz C, Kacan T, Akkar OB, Karakus S, Kacan SB, Ozer H, Cetin A. Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats. Reprod Sci 2015;22:1445-51. [DOI: 10.1177/1933719115584448] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
35 Platteeuw L, D'Hooghe T. Novel agents for the medical treatment of endometriosis. Curr Opin Obstet Gynecol 2014;26:243-52. [PMID: 24978852 DOI: 10.1097/GCO.0000000000000084] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
36 Pittatore G, Moggio A, Benedetto C, Bussolati B, Revelli A. Endometrial Adult/Progenitor Stem Cells: Pathogenetic Theory and New Antiangiogenic Approach for Endometriosis Therapy. Reprod Sci 2013;21:296-304. [DOI: 10.1177/1933719113503405] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
37 Dolapcioglu K, Dogruer G, Ozsoy S, Ergun Y, Ciftci S, Soylu Karapinar O, Aslan E. Theranekron for treatment of endometriosis in a rat model compared with medroxyprogesterone acetate and leuprolide acetate. European Journal of Obstetrics & Gynecology and Reproductive Biology 2013;170:206-10. [DOI: 10.1016/j.ejogrb.2013.05.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Rocha AL, Reis FM, Taylor RN. Angiogenesis and endometriosis. Obstet Gynecol Int. 2013;2013:859619. [PMID: 23766765 DOI: 10.1155/2013/859619] [Cited by in Crossref: 72] [Cited by in F6Publishing: 85] [Article Influence: 8.0] [Reference Citation Analysis]